Gene Techno Science

Gene Techno Science

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan. Learn more

Launch date
Employees
Market cap
AUD56.3m
Enterprise valuation
AUD60m (Public information from Sep 2024)
Sapporo Hokkaido Prefecture (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
JPY2020202120222023202420252026
Revenues1.1b997m1.6b2.8b2.4b470m560m
% growth-(8 %)57 %77 %(12 %)(81 %)19 %
EBITDA(1.2b)(974m)(935m)(589m)(1.3b)--
% EBITDA margin(110 %)(98 %)(60 %)(21 %)(56 %)--
Profit(7.3b)(1.0b)(535m)(657m)(1.4b)--
% profit margin(679 %)(100 %)(34 %)(24 %)(58 %)--
R&D budget898m964m1.2b1.2b1.5b--
R&D % of revenue83 %97 %73 %44 %60 %--
  • Edit

Recent News about Gene Techno Science

Edit
More about Gene Techno Scienceinfo icon
Edit

G-GTS.com operates in the global trading solutions market, focusing on enhancing supply chain efficiency through advanced technology and data analytics. The company serves a diverse range of clients, including manufacturers, distributors, and retailers, who require streamlined logistics and supply chain management. G-GTS.com leverages a business model that integrates software-as-a-service (SaaS) with data-driven insights to optimize inventory management, reduce operational costs, and improve overall supply chain performance. Revenue is generated through subscription fees for its platform and additional services such as consulting and custom analytics.

Keywords: supply chain, logistics, data analytics, SaaS, inventory management, operational efficiency, global trading, technology, consulting, custom analytics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Gene Techno Science

Edit
Celtechnology
ACQUISITION Apr 2019